273 Phase i study of LioCyx-M, autologous hepatitis B virus (HBV)-specific T cell receptor (TCR) T-cells, in recurrent HBV-related hepatocellular carcinoma (HCC) post-liver transplantation
Wenjie Chen(Commercial Aircraft Corporation of China (China)), Qi Zhang(University of Electronic Science and Technology of China), Antonio Bertoletti(Duke-NUS Medical School), Jintao Cheng(Sun Yat-sen University), Fan Yang(Jinan University), Sarene Koh(Singapore Immunology Network), Lu‐En Wai(Duke-NUS Medical School), Royce Fam, Tingting Wang(Shantou University), Xiaofang Zheng(Hunan University)
Cited by 4
Related Papers
Engineering a 3D DNA-Logic Gate Nanomachine for Bispecific Recognition and Computing on Target Cell Surfaces
|Journal of the American Chemical Society|2018|287
A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors
|JCI Insight|2017|239
Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study
|Frontiers in Immunology|2023|204